US universities eye SARS travel bans

Harvard, first to ban Toronto travel, feels vindicated by latest developments.

Written byCatherine Zandonella
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When Harvard University announced a moratorium on travel to SARS-affected Toronto early last week, Canadian newspapers grumbled that it was overkill. But with SARS (severe acute respiratory syndrome) continuing to spread in Toronto, Harvard's move seems increasingly justified, say university health officials. And other Ivy League institutions may follow suit.

"On Monday we were taking heat for our decision, but by Thursday we looked pretty good," said Barry Bloom, dean of the Harvard School of Public Health, Cambridge, speaking of the university's decision to request that its nearly 30,000 students, faculty, and staff refrain from traveling to Toronto.

Reports last week of possible transmission within a church group and at a condominium complex in Toronto seemed to indicate that the so-called "community spread" of the virus had begun. According to Bloom, most epidemiologists define "community spread" as transmission among people who do not know from whom they acquired the virus. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies